DOCSLIB.ORG

Isoaspartic Acid Is Present at Specific Sites in Myelin Basic Protein from Multiple Sclerosis Patients: Could This Represent a Trigger for Disease Onset? Michael G

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Isoaspartic Acid Is Present at Specific Sites in Myelin Basic Protein from Multiple Sclerosis Patients: Could This Represent a Trigger for Disease Onset? Michael G Friedrich et al. Acta Neuropathologica Communications (2016) 4:83 DOI 10.1186/s40478-016-0348-x RESEARCH Open Access Isoaspartic acid is present at specific sites in myelin basic protein from multiple sclerosis patients: could this represent a trigger for disease onset? Michael G. Friedrich1,2*, Sarah E. Hancock1,2, Mark J. Raftery3 and Roger J. W. Truscott1* Abstract Multiple sclerosis (MS) is associated with breakdown of the myelin sheath that coats neurons in the central nervous system. The cause of MS is not known, although the pathogenesis involves destruction of myelin by the immune system. It was the aim of this study to examine the abundant myelin protein, myelin basic protein (MBP), to determine if there are sites of modification that may be characteristic for MS. MBP from the cerebellum was examined from controls and MS patients across the age range using mass spectrometry and amino acid analysis. Amino acid racemization data indicated that myelin basic protein is long-lived and proteomic analysis of MBP showed it to be highly modified. A common modification of MBP was racemization of Asp and this was significantly greater in MS patients. In long-lived proteins, L-Asp and L-Asn can racemize to three other isomers, D-isoAsp, L-isoAsp and D-Asp and this is significant because isoAsp formation in peptides renders them immunogenic. Proteomic analysis revealed widespread modifications of MBP with two surface regions that are altered in MS. In particular, isoAsp was significantly elevated at these sites in MS patients. The generation of isoAsp could be responsible for eliciting an immune response to modified MBP and therefore be implicated in the etiology of MS. Introduction age-related post-translational modifications (PTMs) were MS has long been thought to be an autoimmune disease. localized to unstructured regions [19] and racemization, Injection of brain homogenates into animals results in which involves conversion of L- to D-amino acid re- demyelination resembling that seen in MS [33] and a sidues, was found to be the most abundant type of body of data, including the presence of antibodies to PTM [39]. D-amino acids at some sites were present myelin components in MS patients, supports a role at levels that exceeded the amount of the precursor for an autoimmune response in the genesis of human L-amino acid [21]. MS [32, 42]. In humans, major proteins from cataract lenses are MBP accounts for 35 % of myelin protein and is characterized by specific racemization sites that differ intrinsically unstructured [16] Recently, MBP and other from those in comparable age-matched normal lenses proteins in myelin were shown to be long-lived [35]. [18, 20, 21]. This finding implies that pathways of Over time, long-lived proteins degrade and this time- protein degradation in the body may possibly determine dependent deterioration has been well studied in the disease outcome. In long-lived proteins, Asp and Asn lens, a tissue with no protein turnover. In lens proteins, residues are particularly sensitive to racemization, undergoing a spontaneous cyclisation reaction that leads to the formation of L-Asp, D-Asp, L-isoAsp and D- * Correspondence: [email protected] 1Illawarra Health and Medical Research Institute, University of Wollongong, isoAsp (see Fig. 2). isoAsp residues are typically present Wollongong, NSW 2522, Australia in the highest amounts [13]. Full list of author information is available at the end of the article © 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Friedrich et al. Acta Neuropathologica Communications (2016) 4:83 Page 2 of 12 Modifications on this scale inevitably have conse- by SDS-PAGE (Additional file 1: Figure S2). Since quences for protein structure and can lead to a func- PTMs, such as those associated with aging, can cause tional decline of the protein [34]. Recently it has been major alterations to the properties of proteins, MBP shown that the formation of isoAsp can also lead to was not separated into isoforms (charge isomers) prior altered immunogenicity of peptides/proteins, inducing to proteomic analyses [22]. both T and B cell immunity [11]. Thus, like citrulline formation from Arg residues, conversion of Asp/Asn to Amino acid analysis isoAsp, can potentially induce an immune response to D-amino acid content of MBP samples was determined self-antigens [10]. In the current study we examined the by amino acid analysis as described [18]. Three separate hypothesis that since MBP is long-lived and unstruc- runs were carried out for each sample on an Agilent tured it, like lens proteins, may also undergo significant 1100 HPLC system. covalent alterations. For the reasons outlined above, particular reference was paid to Asp/Asn racemizaton to Capillary LC mass spectrometry isoAsp. If specific PTMs such as these were found in the Capillary LC mass spectrometry was undertaken as MBP from MS patients, then they could play a role in described [21]. Briefly, MBP (~50 μg) was digested with the etiology of MS by provoking an immune response to sequence grade trypsin (1 μg) (Promega) for 16 h at 37 ° the selectively modified myelin. C. Peptides were desalted and concentrated using a Ziptip (0.6 μL, C18 resin; Millipore) and freeze dried. Materials and methods The lyophilised peptides were re-suspended in formic Tissue samples acid:heptafluorobutyric acid:water (0.1:0.05:98.85). Tan- Cerebellum samples from control (n = 21) and MS pa- dem mass spectra were acquired after LC using a Thermo tients (n = 8) were obtained from the New South Wales LTQ Orbitrap as described [21]. Tissue Resource Centre at the University of Sydney with Data were searched against the Swiss-Prot database approval from the University of Wollongong ethics com- with a range of PTMs using MASCOT (Matrix Science, mittee (Ethics #11/267). MS patients were diagnosed as UK), with enzyme specificity set to trypsin. Peptide follows: four with secondary progressive MS (ages 65, tolerance: 1 ppm; fragment tolerance: 0.6 Da with 1 68, 48, 60), two with relapsing remitting MS (ages 70 missed cleavage. The following PTMs were listed as and 72) and two with primary progressive MS (ages 36 variable modifications: deamidation (N,Q,R), oxidation and 62). All MS samples displayed microscopically small (H,W,M), methylation (R) and phosphorylation (S,T). lesions with the exception of the 68 year-old patient. Routinely greater than 80 % sequence coverage of MBP Control and MS samples were analysed separately, blind was observed. To confirm assignments, tandem mass with respect to age and severity of MS. Further details spectrometric fragmentation of each peak was per- are provided in Additional file 1: Tables S1 and S2. formed and synthetic peptides incorporating the par- ticular modified amino acid (see below for list of Homogenization of human brain tissue commercial standards) were run using the same Frozen cerebellum (Gyri of the posterior lobe) from con- method to confirm identity by comparison of retention trols (105 +/− 11 mg) and MS patients (115 +/− 13 mg) time and MS/MS. was pulverized then homogenized as detailed in Norris et. al. [30] After homogenization, each sample was Data analysis transferred to a 5 mL glass tube and centrifuged (1000 g, The doubly charged ions [FFGGDR m/z = 349.66, FFG 10 min) at 4 °C. Myelin was enriched by use of a sucrose GD(Cit)GAPK m/z = 526.76, GVDAQGTLSK m/z = gradient as described in Larocca and Norton [23]. 488.25, YLATASTMDHAR m/z = 668.82, TAHYGSLP QK m/z = 551.28 and TAHYGSLPEK m/z = 551.78] and Purification of MBP triply charged ions [TQDENPVVHFFK m/z = 487.57 and Myelin basic protein was enriched with modifications to HRDTGILDSIGR m/z = 447.24] for MBP-derived tryptic the protocol of Chevalier and Allen [7]. Briefly, the peptides were utilised for relative quantification. Their enriched myelin fraction was re-suspended in 50 mM intensities from the extracted ion chromatogram (XIC) Tris buffer (pH 7.4) and centrifuged (21,000 g, 20 min). were determined using Xcalibur software. Peak areas of The supernatant was discarded and the pellet re- each peptide were calculated using a smoothing method extracted. The pellet was re-suspended in 50 mM [Gaussian, 7 points]. The MS/MS spectrum of each pep- acetic acid (1 mL) and centrifuged (21,000 g,20min) tide was matched to the XIC, ensuring that the peak and the pellet re-extracted with 50 mM acetic acid. areas used corresponded to that of the matched peptide. The acetic acid extracts were combined and freeze The percentage of modification was calculated by using: dried. Greater than 90 % purity of MBP was confirmed [Modified/(Modified + Non- modified)] × 100. Friedrich et al. Acta Neuropathologica Communications (2016) 4:83 Page 3 of 12 Peptide standards residues present in MBP, on average, approximately one FFGGDR (MBP tryptic peptide 44–49), FFGGDRGAPK Asp residue in every MBP polypeptide is racemized MS and FFGGD(Cit)GAPK (MBP tryptic peptide 44–53), patients. In order to pinpoint the exact sites of modifica- GVDAQGTLSK, (MBP tryptic peptide 143–152), HRD tion of MBP, samples were treated with trypsin and the TGILDSIGR (MBP tryptic peptide 32–43), YLATAST peptides characterized by capillary liquid chromatog- MDHAR (MBP tryptic peptide 14–25), TAHYGSLPQK raphy tandem mass spectrometry (LC-MS).
Load more

Recommended publications
  • Deamidation of Human Proteins
    Deamidation of human proteins N. E. Robinson*† and A. B. Robinson‡ *Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125; and ‡Oregon Institute of Science and Medicine, Cave Junction, OR 97523 Communicated by Frederick Seitz, The Rockefeller University, New York, NY, August 31, 2001 (received for review May 8, 2001) Deamidation of asparaginyl and glutaminyl residues causes time- 3D structure is known (23). This method is more than 95% dependent changes in charge and conformation of peptides and reliable in predicting relative deamidation rates of Asn residues proteins. Quantitative and experimentally verified predictive cal- within a single protein and is also useful for the prediction of culations of the deamidation rates of 1,371 asparaginyl residues in absolute deamidation rates. a representative collection of 126 human proteins have been It is, therefore, now possible to compute the expected deami- performed. These rates suggest that deamidation is a biologically dation rate of any protein for which the primary and 3D relevant phenomenon in a remarkably large percentage of human structures are known, except for very long-lived proteins. These proteins. proteins require measurement of the 400 Gln pentapeptide rates. in vivo deamidation ͉ asparaginyl residues Materials and Methods Calculation Method. The Brookhaven Protein Data Bank (PDB) eamidation of asparaginyl (Asn) and glutaminyl (Gln) was searched to select 126 human proteins of general biochem- Dresidues to produce aspartyl (Asp) and glutamyl (Glu) ical interest and of known 3D structure without bias toward any residues causes structurally and biologically important alter- known data about their deamidation, except for 13 proteins (as ations in peptide and protein structures.
    [Show full text]
  • Deamidation, Acylation and Proteolysis of a Model Peptide in PLGA Films ⁎ M.L
    Journal of Controlled Release 112 (2006) 111–119 www.elsevier.com/locate/jconrel Deamidation, acylation and proteolysis of a model peptide in PLGA films ⁎ M.L. Houchin a, K. Heppert b, E.M. Topp a, a Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Ave., Lawrence, KS 66047, United States b Higuchi Biosciences Centers, The University of Kansas, Lawrence, KS, United States Received 8 December 2005; accepted 30 January 2006 Available online 9 March 2006 Abstract The relative rates of deamidation, acylation and proteolysis (i.e. amide bond cleavage) were determined for a model peptide (VYPNGA) in poly (DL-lactide-co-glycolide) films. Films were stored at 70°C and either 95%, 75%, 60%, 45%, 28%, or ∼0% relative humidity and at 37°C and 95% relative humidity. Peptide degradation products were identified by ESI+MS/MS and quantitated by LC/MS/MS. Extensive overlap of degradation mechanisms occurred, producing a complex mixture of products. Acylation was the dominant peptide degradation reaction (10–20% of total peptide) at early stages of PLGA hydrolysis and at intermediate relative humidity (60–45% RH). Deamidation and proteolysis were dominant (25–50% and 20–40% of total peptide, respectively) at later stages and at high relative humidity (95–75% RH). Understanding the relative rates of each peptide degradation reaction will allow for improved design of PLGA formulations that preserve the stability of peptide and protein drugs. © 2006 Elsevier B.V. All rights reserved. Keywords: PLGA; Deamidation; Acylation; Proteolysis; Peptide stability 1. Introduction bonds produces lactic and glycolic acid, which are easily metabolized.
    [Show full text]
  • Nobel Lecture by Roger Y. Tsien
    CONSTRUCTING AND EXPLOITING THE FLUORESCENT PROTEIN PAINTBOX Nobel Lecture, December 8, 2008 by Roger Y. Tsien Howard Hughes Medical Institute, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0647, USA. MOTIVATION My first exposure to visibly fluorescent proteins (FPs) was near the end of my time as a faculty member at the University of California, Berkeley. Prof. Alexander Glazer, a friend and colleague there, was the world’s expert on phycobiliproteins, the brilliantly colored and intensely fluorescent proteins that serve as light-harvesting antennae for the photosynthetic apparatus of blue-green algae or cyanobacteria. One day, probably around 1987–88, Glazer told me that his lab had cloned the gene for one of the phycobilipro- teins. Furthermore, he said, the apoprotein produced from this gene became fluorescent when mixed with its chromophore, a small molecule cofactor that could be extracted from dried cyanobacteria under conditions that cleaved its bond to the phycobiliprotein. I remember becoming very excited about the prospect that an arbitrary protein could be fluorescently tagged in situ by genetically fusing it to the phycobiliprotein, then administering the chromophore, which I hoped would be able to cross membranes and get inside cells. Unfortunately, Glazer’s lab then found out that the spontane- ous reaction between the apoprotein and the chromophore produced the “wrong” product, whose fluorescence was red-shifted and five-fold lower than that of the native phycobiliprotein1–3. An enzyme from the cyanobacteria was required to insert the chromophore correctly into the apoprotein. This en- zyme was a heterodimer of two gene products, so at least three cyanobacterial genes would have to be introduced into any other organism, not counting any gene products needed to synthesize the chromophore4.
    [Show full text]
  • BOSTON UNIVERSITY SCHOOL of MEDICINE Dissertation
    BOSTON UNIVERSITY SCHOOL OF MEDICINE Dissertation DEAMIDATION AND RELATED PROBLEMS IN STRUCTURAL ANALYSIS OF PEPTIDES AND PROTEINS by NADEZDA P. SARGAEVA B.S., St. Petersburg State Polytechnical University, 2002 M.S., St. Petersburg State Polytechnical University, 2004 Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy 2012 Approved by First Reader Peter B. O’Connor, Ph.D. Associate Professor of Biochemistry Second Reader Cheng Lin, Ph.D. Assistant Professor of Biochemistry Dedications I dedicate this thesis to my Family iii Acknowledgments I would like to express my deepest gratitude to my advisor, Prof. Peter B. O’Connor. We met in St. Petersburg, Russia in 2004 and you believed in my abilities and you gave me an opportunity to be a part of such a great mass spectrometry program. I also want to thank you for your support and your guidance throughout my Ph.D. studies. Thank you for pushing me to achieve my goals of learning and becoming a better scientist, and for the opportunity you gave me to build up my professional and scientific network. Your help, your advice, and your encouragement in building up my professional career are very much appreciated. Prof. Cheng Lin, thank you for being my second reader and mentor. Working with you has always been a pleasure – I highly value your well thought out ideas, your constant use of the scientific principle, and your willingness to follow up regarding the data, the future directions, etc. I truly appreciate your attention to details, your regular availability and willingness to help me hands on.
    [Show full text]
  • Deamidation in Moxetumomab Pasudotox Leading to Conformational Change And
    bioRxiv preprint doi: https://doi.org/10.1101/761635; this version posted September 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Deamidation in Moxetumomab Pasudotox Leading to Conformational Change and Immunotoxin Activity Loss X. Lu, S. Lin, N. De Mel, A. Parupudi, M. Pandey, J. Delmar, X. Wang, and J. Wang Running Title: Deamidation impacts immunotoxin activity 1 bioRxiv preprint doi: https://doi.org/10.1101/761635; this version posted September 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Asparagine deamidation is a common posttranslational modification in which asparagine is converted to aspartic acid or isoaspartic acid. By introducing a negative charge, deamidation could potentially impact the binding interface and biological activities of protein therapeutics. We identified a deamidation variant in moxetumomab pasudotox, an immunotoxin Fv fusion protein drug derived from a 38-kilodalton (kDa) truncated Pseudomonas exotoxin A (PE38) for the treatment of hairy-cell leukemia. Although the deamidation site, Asn-358, was outside of the binding interface, the modification had a significant impact on the biological activity of moxetumomab pasudotox. Surprisingly, the variant eluted earlier than its unmodified form on anion exchange chromatography, which suggests a higher positive charge.
    [Show full text]
  • Modeling the Deamidation of Asparagine Residues Via Succinimide Intermediates
    J Mol Model (2001) 7:147–160 DOI 10.1007/s008940100025 ORIGINAL PAPER F. Aylin (Sungur) Konuklar · Viktorya Aviyente Taner Zafer Sen · Ivet Bahar Modeling the deamidation of asparagine residues via succinimide intermediates Received: 29 June 2000 / Accepted: 22 March 2001 / Published online: 24 May 2001 © Springer-Verlag 2001 Abstract Density functional theory (B3LYP/6-31G*) Asp) in a ratio of 1:3. [6] In addition, small amounts of has been used to study the cyclization, deamidation and D-aspartic acid and D-isoaspartic acid were observed, in- hydrolysis reactions of a model peptide. Single point en- dicating slow racemization of the cyclic imide. ergy calculations with the polarized continuum model Spontaneous deamidation through the cyclization drastically lower the activation energy for cyclization in mechanism has been implicated in the inactivation of a a basic medium. Confirmation of the experimental re- number of enzymes. [7] The deamidation reaction has a sults that cyclization is slower than deamidation in acidic much shorter half-life than that for peptide bond hydroly- media and the opposite is true in basic media has enabled sis, varying from days to weeks depending on the amino us to propose mechanisms for both processes. acid sequence. [3] Antibodies that catalyze the deamida- tion and β-aspartyl shift of modified asparaginyl–glycyl Keywords Deamidation · Succinimide · Density dipeptides have been reported. [8] Two classes of anti- functional theory · Hydrolysis of peptides bodies that control theisoaspartate to aspartate product ra- tio were generated. One class catalyzes only the hydroly- sis of succinimide and the other catalyzes both the rate- Introduction limiting deamidation and the subsequent succinimide hy- drolysis.
    [Show full text]
  • Can the Fact That Myelin Proteins Are Old and Break Down Explain the Origin of Multiple Sclerosis in Some People?
    Journal of Clinical Medicine Review Can the Fact That Myelin Proteins Are Old and Break down Explain the Origin of Multiple Sclerosis in Some People? Roger J. W. Truscott * and Michael G. Friedrich Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW 2522, Australia; [email protected] * Correspondence: [email protected]; Tel.: +61-2-4298-3503; Fax: +61-2-4221-8130 Received: 11 July 2018; Accepted: 12 September 2018; Published: 14 September 2018 Abstract: Recent discoveries may change the way that multiple sclerosis (MS) is viewed, particularly with regard to the reasons for the untoward immune response. The fact that myelin proteins are long-lived, and that by the time we are adults, they are extensively degraded, alters our perspective on the reasons for the onset of autoimmunity and the origin of MS. For example, myelin basic protein (MBP) from every human brain past the age of 20 years, is so greatly modified, that it is effectively a different protein from the one that was laid down in childhood. Since only a subset of people with such degraded MBP develop MS, a focus on understanding the mechanism of immune responses to central nervous system (CNS) antigens and cerebral immune tolerance appear to be worthwhile avenues to explore. In accord with this, it will be productive to examine why all people, whose brains contain large quantities of a “foreign antigen”, do not develop MS. Importantly for the potential causation of MS, MBP from MS patients breaks down differently from the MBP in aged controls. If the novel structures formed in these MS-specific regions are particularly antigenic, it could help explain the origin of MS.
    [Show full text]
  • Racemization Ages (Radiocarbon Dating/Fossil Bones) JEFFREY L
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 3, pp. 914-917, March, 1974 Concordance of Collagen-Based Radiocarbon and Aspartic-Acid Racemization Ages (radiocarbon dating/fossil bones) JEFFREY L. BADA*t, ROY A. SCHROEDERt, REINER PROTSCHt, AND RAINER BERGERt tScripps Institution of Oceanography, University of California, San Diego, La Jolla, Calif. 92037; and tDepartments of Anthropology and Geography and Institute of Geophysics & Planetary Physics, University of California, Los Angeles, Los Angeles, Calif. 90024 Communicated by William A. Nierenberg, October 19, 1973 ABSTRACT By determining the extent of racemization racemization reaction. The only assumption required, in using of aspartic acid in a well-dated bone, it is possible to calcu- this approach, is that the average temperature experienced by late the in situ first-order rate constant for the intercon- version of the L and D enantiomers of aspartic acid. the "calibration" sample is representative of the average Collagen-based radiocarbon-dated bones are shown to be temperature experienced by other samples from the deposit. suitable samples for use in "calibrating" the racemization Many radiocarbon dates suitable for calibrating the aspar- reaction. Once the aspartic-acid racemization reaction has tic-acid racemization reaction have been derived from colla- been "calibrated" for a site, the reaction can be used to date other bones from the deposit. Ages deduced by this gen. However, it is important to show the dependability of method are in good agreement with radiocarbon ages. collagen dates by comparison with measurements made on These results provide evidence that the aspartic-acid charcoal or other organic materials. racemization reaction is an important chronological tool In this study we establish the dependability of radiocarbon for dating bones either too old or too small for radiocarbon collagen dates and then show the equivalence of collagen and dating.
    [Show full text]
  • ISOQUANT® Isoaspartate Detection Kit Instructions for Use of Product MA1010
    TECHNICAL BULLETIN ISOQUANT® Isoaspartate Detection Kit Instructions for use of Product MA1010 Promega Corporation · 2800 Woods Hollow Road · Madison, WI 53711-5399 USA · Toll Free in USA 800-356-9526 · 608-274-4330 · Fax 608-277-2516 Revised 10/17 www.promega.com TBI001 · Revised 10/17 TBI001 ISOQUANT® Isoaspartate Detection Kit All technical literature is available on the Internet at: www.promega.com/protocols/ Please visit the web site to verify that you are using the most current version of this Technical Bulletin. Please contact Promega Technical Services if you have questions on use of this system. E-mail: [email protected] 1. Description..........................................................................................................2 A. Intended Use .........................................................................................................2 B. Assay Principle .....................................................................................................2 C. ISOQUANT® Isoaspartate Detection Kit ..........................................................4 D. Assay Sensitivity...................................................................................................4 2. Product Components and Storage Conditions ............................................5 3. HPLC Detection Protocol .................................................................................5 A. Planning the Assay...............................................................................................6 B. Sample Preparation..............................................................................................6
    [Show full text]
  • Phenylalanine Post Translational Modifications
    Phenylalanine Post Translational Modifications Pilous and unseparable Fitzgerald never abreacts faultlessly when Kenn producing his shorelines. Exciting Simmonds reproves almostunfearfully gloriously, while Smith though always Barnard japes earwigged his krone his gusset magnetrons glancingly, disbudding. he malleates so yesteryear. Inofficious and septimal Raimund tariff Modified proteins of this type cannot be sequenced by the Edman method, they are blocked. The acetylation of proteins is mainly a cotranslational and posttranslational process. Furthermore, these biocontained cells will grow more rapidly than first generation biocontained cells, which can accelerate the rate of industrial production of metabolites or proteins. Results showed highly efficient incorporation at both positions. All work on the mice was performed at a sterile workbench in the same room. Advanced glycation endproducts: what is their relevance to diabetic complications? Protein posttranslational modifications: the chemistry of proteome diversifications. Tekle E, Wang T, Stadtman ER, Yang DCH, Chock PB: Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Synonyms: racemization, epimerisation, stereoinversion. Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family. Zhang Q, Monroe ME, Schepmoes AA, Clauss TRW, Gritsenko MA, Meng D, Petyuk VA, Smith RD, Metz TO: Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: Respiration, apoptosis, and human disease. Mitochondrial Pathophysiology, Reactive Oxygen Species, and Cardiovascular Diseases. Raise the profile of a research area by leading a Special Issue. PTMs are then immunodetected using fluorescence tagging. The carbamido diacetyl reaction: a test for citrulline.
    [Show full text]
  • Separation and Characterization of Deamidated Isoforms in Insulin Analogue and Its Underlying Mechanism
    Original Research Article Separation and Characterization of Deamidated Isoforms in Insulin Analogue and its Underlying Mechanism Krishnappa Mane1,*, Koduru Srivatsa2, Ashutosh Naik3, Phanichand Kodali4 1,3Principal Scientist, 2Scientist, 4Associate Scientific Manager II, Biocon Research Centre, Biocon Research Limited, Bangalore, Karnataka *Corresponding Author: Email: [email protected] Abstract Deamidation of proteins has remained an elusive phenomenon largely down to the gap that exists in its understanding. One of the primary reasons, is that the experimentation involved is time consuming. However, it remains one of the most important phenomenon in proteomics both in-vitro as well as in-vivo. Deamidation results in the quick conversion of an asparagine residue to a mixture of isoaspartate and aspartate. In glutamine residues deamidation occurs at a much lower rate. Deamidation of asparagine residues is one of the most common post-translational modifications occurring in therapeutic proteins produced using recombinant DNA technology and is the major cause for degradation of bio- pharmaceuticals. Herein, we present the separation and characterization of deamidated Isoforms in a recombinantly produced Insulin analogue by ion exchange chromatography and enzymatic digestion. The deamidation site was confirmed by using state of the art technique: LC-ESI-MS-MS. Additionally secondary structural differences were observed between the unmodified and deamidated variant of the protein. Keywords: Deamidated isoforms, Insulin analogue. Introduction response to the therapeutic protein.(2) Therefore, Protein post-translational modification (PTM) identifying and understanding PTMs is critical in the increase the functional diversity of the proteome by the study of cell biology, disease treatment and prevention. covalent addition of functional groups or proteins, The mechanism of formation of the de-amidated proteolytic cleavage of regulatory subunits or species from these amino acids are given in (Fig.
    [Show full text]
  • Enzymatic Deamidation of Methyl-Accepting Chemotaxis
    Proc. NatL Acad. Sci. USA Vol. 80, pp. 3599-3603, June 1983 Biochemistry Enzymatic deamidation of methyl-accepting chemotaxis proteins in Escherichia coli catalyzed by the cheB gene product (methylation/CheB-dependent modification/sensory adaptation) MARILYN R. KEHRY*, MARTHA W. BONDtt, MICHAEL W. HUNKAPILLERt, AND FREDERICK W. DAHLQUIST* *Institute of Molecular Biology, University of Oregon, Eugene, Oregon 97403; and tDivision of Biology 156-29, California Institute of Technology, Pasadena, California 91125 Communicated by George Streisinger, March 11, 1983 ABSTRACT The methyl-accepting chemotaxis proteins (MCPs) methyl ester of glutamic acid (20-23). A protein methylesterase of Escherichia coli undergo reversible methylation that has been encoded by the cheB gene balances the methyltransferase ac- correlated with adaptation of cells to environmental stimuli. MCPI, tivity by removing methyl groups (24, 25). Each MCP has mul- the product of the tsr gene, accepts methyl groups at multiple sites tiple sites at which methylation and demethylation may occur that are located on two tryptic peptides, denoted KI and RI. A (26-29). For example, MCPI may accept a maximum of six second modification of the MCPs, which is not methylation, has methyl groups, and MCPII accepts at least four methyl groups been designated the CheB-dependent modification. A CheB-de- (30, 31). pendent modification occurs on methyl-accepting peptide KI and A second covalent modification of the MCPs also occurs at allows additional methyl groups to be incorporated into this pep- multiple sites and is dependent on the presence of the cheB tide. We have performed partial amino acid sequence analyses on radiolabeled peptides Ki and RI derived from MCPI and have gene (32, 33).
    [Show full text]